Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Specific mutations of map kinase 4 (MKK4) in human tumor cell lines identify it as a tumor suppressor in various types of cancer

Specific mutations of map kinase 4 (MKK4) in human tumor cell lines identify it as a tumor suppressor in various types of cancer

US Patent 5989885 · Granted Nov 23, 1999

Estimated economic value: $2,359,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthetic genetic elements for biomanufacture2024
Tumor suppressor designated TS10Q23.32014
Tumor suppressor designated TS10Q23.32010
Tumor suppressor designated TS10q23.32007
Tumor suppressor designated TS10q23.32006
Chromosome 17P-linked prostate cancer susceptibility gene2005
Chromosome 17P-linked prostate cancer susceptibility gene2005
Tumor suppressor designated TS10q23.32002
BRG1 is a tumor suppressor that is mutated in prostate and other cancer types2002
BRG1 is a tumor suppressor that is mutated in prostate and other cancer types2002
TMPRSS2 is a tumor suppressor2002
TMPRSS2 is a tumor suppressor2002